{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:18:53Z","timestamp":1789985933813,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Ulm University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation, Inc.","doi-asserted-by":"crossref","award":["A-7328"],"award-info":[{"award-number":["A-7328"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.expneurol.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T06:38:59Z","timestamp":1479883139000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6\/2 fragment model"],"prefix":"10.1016","volume":"288","author":[{"given":"Tanja","family":"Hering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kojer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Birth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Hallitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem","family":"Taanman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.10.017_bb0005","series-title":"Practical Statistics for Medical Research","first-page":"199","article-title":"Analysis of skewed data","author":"Altman","year":"1991"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201308006","article-title":"The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission","volume":"204","author":"Anand","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0015","first-page":"1074","article-title":"Mitochondrial fission and fusion in human diseases","volume":"370","author":"Archer","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jemt.1070270303","article-title":"Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria","volume":"27","author":"Bereiter-Hahn","year":"1994","journal-title":"Microsc. Res. Tech."},{"issue":"12","key":"10.1016\/j.expneurol.2016.10.017_bb9000","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","article-title":"Mutant huntingtin and mitochondrial dysfunction","volume":"31","author":"Bossy-Wetzel","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2016.10.017_bb9005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.cellbio.22.010305.104638","article-title":"Mitochondrial fusion and fission in mammals","volume":"22","author":"Chan","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0030","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2006.06.021","article-title":"Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling","volume":"126","author":"Cipolat","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/emmm.201000102","article-title":"Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli","author":"Costa","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0045","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/emboj.2012.65","article-title":"Shaping the role of mitochondria in the pathogenesis of Huntington's disease","volume":"31","author":"Costa","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0050","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tins.2012.06.004","article-title":"Caspase-3 in the central nervous system: beyond apoptosis","volume":"35","author":"D'Amelio","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-5956-9-59","article-title":"Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease","volume":"9","author":"Diedrich","year":"2011","journal-title":"Proteome Sci."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0060","article-title":"Characterization of striatal neuronal loss and atrophy in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Dodds","year":"2014","journal-title":"PLoS Curr."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0065","doi-asserted-by":"crossref","first-page":"30761","DOI":"10.1016\/S0021-9258(18)47344-9","article-title":"CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme","volume":"269","author":"Fernandes-Alnemri","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","article-title":"OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion","volume":"126","author":"Frezza","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.28.1.23","article-title":"Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies","volume":"28","author":"Goebel","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0080","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1083\/jcb.200906083","article-title":"Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells","volume":"187","author":"Head","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0090","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data","volume":"8","author":"Hellemans","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2015.02.004","article-title":"Selective striatal mtDNA depletion in end-stage Huntington's disease R6\/2 mice","volume":"266C","author":"Hering","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057932","article-title":"Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mito.2003.10.002","article-title":"Laser micro-irradiation of mitochondria: is there an amplified mitochondrial death signal in neural cells?","volume":"3","author":"Khodjakov","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/NMM:1:3:183","article-title":"Cytochrome C and caspase-9 expression in Huntington's disease","volume":"1","author":"Kiechle","year":"2002","journal-title":"Neruomol. Med."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0115","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/cdd.2012.128","article-title":"Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity","volume":"20","author":"Kushnareva","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2015.01.004","article-title":"Regulation of mitochondrial transport in neurons","author":"Lin","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an ExpandedCAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0135","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.neurobiolaging.2015.02.004","article-title":"Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits","volume":"36","author":"Mehrotra","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0140","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1471-4159.2006.03998.x","article-title":"Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease","volume":"98","author":"Mormone","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0150","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2016.10.017_bb9010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.06741.x","article-title":"Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum","volume":"114","author":"Oliveira","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0160","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.bbamcr.2013.02.002","article-title":"New insights into the function and regulation of mitochondrial fission","volume":"1833","author":"Otera","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"4\u20135","key":"10.1016\/j.expneurol.2016.10.017_bb9020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/cdd.2012.95","article-title":"Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency","volume":"20","author":"Ramonet","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0003-2697(91)90094-A","article-title":"Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form","volume":"199","author":"Schagger","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1534-5807(01)00116-2","article-title":"A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis","volume":"2","author":"Scorrano","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0190","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbagen.2014.10.012","article-title":"Mitochondrial proteolysis: its emerging roles in stress responses","volume":"1850","author":"Sekine","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0200","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0205","series-title":"Studies on Brain Biopsies of Patients with Huntington's Chorea","author":"Tellet-Nagel","year":"1974"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0215","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","article-title":"Fission and selective fusion govern mitochondrial segregation and elimination by autophagy","volume":"27","author":"Twing","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0225","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","article-title":"The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage","volume":"21","author":"Varanita","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0230","first-page":"148","article-title":"hMTH1 expression protects mitochondria from Huntington's disease-like impairment","volume":"49C","author":"Ventura","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","article-title":"Expression pattern of apoptosis-related markers in Huntington's disease","volume":"109","author":"Vis","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.devcel.2011.08.026","article-title":"Dual role of mitofilin in mitochondrial membrane organization and protein biogenesis","volume":"21","author":"von der Malsburg","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","article-title":"Mitochondrial dynamics and metabolic regulation","volume":"27","author":"Wai","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0250","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0255","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.molcel.2008.07.010","article-title":"Opa1-mediated cristae opening is Bax\/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization","volume":"31","author":"Yamaguchi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0265","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.10.017_bb0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jmb.2012.05.004","article-title":"Role of MINOS in mitochondrial membrane architecture: cristae morphology and outer membrane interactions differentially depend on mitofilin domains","volume":"422","author":"Zerbes","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0275","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1515\/hsz-2012-0239","article-title":"Mitofilin complexes: conserved organizers of mitochondrial membrane architecture","volume":"393","author":"Zerbes","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.10.017_bb0280","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.2003.02105.x","article-title":"Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease","volume":"87","author":"Zhang","year":"2003","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861630396X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861630396X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:29:11Z","timestamp":1718897351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861630396X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":58,"alternative-id":["S001448861630396X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.10.017","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6\/2 fragment model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}